252 results
Page 5 of 13
8-K
c5pdqktklv2721rr1ga
8 Mar 19
Completion of Acquisition or Disposition of Assets
4:05pm
424B3
wbsbn8 f5
4 Feb 19
Prospectus supplement
5:52pm
S-4/A
2to921xacty9
14 Jan 19
Registration of securities issued in business combination transactions (amended)
12:00am
S-4
h135flq3afx 6m7s
4 Jan 19
Registration of securities issued in business combination transactions
5:05pm
8-K
2o0i e10vcg
4 Jan 19
Departure of Directors or Certain Officers
8:45am
8-K
wkcbwxf6fqo3mhb5lb
20 Dec 18
Departure of Directors or Certain Officers
7:00am
425
EX-2.1
tbfy06zard
8 Nov 18
Business combination disclosure
6:41am
425
qmkdv x49
8 Nov 18
Business combination disclosure
6:41am
8-K
EX-2.1
m0wkjo
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
pcnthwlbm ln9b
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
EX-1.1
l98yj
2 Aug 18
Entry into a Material Definitive Agreement
8:00am
8-K
1f9y410yhyw
29 May 18
Departure of Directors or Certain Officers
5:15pm